Celldex Therapeutics Inc (NASDAQ:CLDX)

Delayed Data
As of 4:02pm ET
 -0.32 / -1.09%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 67.00, with a high estimate of 68.00 and a low estimate of 59.00. The median estimate represents a +131.43% increase from the last price of 28.95.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.12%
Growthannually -18.09%


Growthquarterly 129.89%
Growthannually -71.62%
Key to the earnings and sales forecast charts.